2-Pyridylphosphine Rhodium Complexes
3H); 8.60 (s, 1H); 8.55 (s, 1H); 7.97 (m, 3H); 7.78 (m, 3H); 7.52
(m, 1H); 7.45 (m, 1H); 7.42 (m, 3H); 7.21 (d, 1H); 6.90 (d, 1H);
2.61 (s, 3H); 2.52 (s, 3H). 19F NMR (293 K, CDCl3): δ -162.02
(m, 2F); -159.40 (t, 1F-); -150.37 (s, 4F-BF4); -116.43 (m, 2F).
IR (Nujol mull, cm-1): 1618 (1642sh) m, ν(CN); 1569 m, ν(CN).
[(4,4′-Me2-bipy)(C6F5)Pd(µ-PPhPy2)Rh(COD)](BF4)2 (4). To
a stirred solution of [Rh2(µ-Cl)2(COD)2] (45.9 mg, 0.093 mmol)
in acetone (20 mL) was added AgBF4 (36.2 mg, 0.186 mmol). After
30 min, the AgCl formed was filtered through Celite, and solid
[Pd(C6F5)(4,4′-Me-bipy)(PPhPy2)](BF4) (150.0 mg, 0.186 mmol)
was added to the yellow solution. The mixture was stirred for 20
min more, the solvent evaporated to dryness, and the residue stirred
with 5 mL of thf (thf ) tetrahydrofuran) affording a yellow solid
that was filtered and vacuum-dried. The solid was recrystallized
from CH2Cl2/ethanol. Yield 164.9 mg (80%). Anal. Calcd for
C42H37N4B2F13PPdRh: C, 45.58; H, 3.37; N, 5.06. Found: C, 45.79;
H, 3.24; N, 4.94. 31P NMR (293 K, (CD3)2CO): δ 49.61. 1H NMR
(293 K, (CD3)2CO): δ 9.84 (m, 2H); 9.40 (d, 2H); 8.67 (s, 1H);
8.58 (s, 1H); 8.29 (m, 2H); 7.96 (m, 2H); 7.88 (m, 1H); 7.75 (m,
1H); 7.62 (m, 4H); 7.53 (d, 1H); 6.93 (d, 1H); 6.72 (d, 1H); 2.61
(s, 3H); 2.43 (s, 3H). 19F NMR (293 K, (CD3)2CO): δ -117.38
(m, 2F); -150.33 (s, 4F-BF4); -158.45 (t, 1F); -160.10 (m, 2F).
IR (Nujol mull, cm-1): 1622 m, ν(CN); 1586 m, ν(CN); 1564 m,
ν(CN); 1559, ν(CN).
[(4,4′-Me2-bipy)(C6F5)Pd(µ-PPhPy2)Rh(TFB)](BF4)2 (5a). Pre-
pared as described for 4 but using [Rh2(µ-Cl)2(TFB)2] (67.8 mg,
0.093 mmol) instead of [Rh2(µ-Cl)2(COD)2]. Yield 166.5 mg (73%).
Anal. Calcd for C46H31N4B2F17PPdRh: C, 45.12; H, 2.55; N, 4.57.
Found: C, 45.20; H, 2.80; N, 4.39. 31P NMR (293 K, (CD3)2CO):
δ 47.68. 1H NMR (293 K, (CD3)2CO): δ 9.73 (t, 2H, H-3-Pycoord);
9.12 (d, 2H, H-6-Pycoord); 8.70 (s, 1H, 4,4′-Me2-bipy); 8.63 (s, 1H,
4,4′-Me2-bipy); 8.29 (m, 2H, H-4-Pycoord); 7.99 (m, 1H, Ph); 7.91
(m, 3H, H-5-Pycoord); 7.91 (m, 1H, 4,4′-Me2-bipy); 7.76 (m, 2H,
Ph); 7.48 (m, 4H, Ph); 7.48 (m, 4H, 4,4′-Me2-bipy); 7.03 (d, 1H,
4,4′-Me2-bipy); 5.13 (m, broad, 2H-TFB); 4.00 (s, broad, 4H-TFB);
2.61 (s, 3H, 4,4′-Me2-bipy); 2.47 (s, 3H, 4,4′-Me2-bipy). 19F NMR
(293 K, (CD3)2CO): δ -160.11 (m, 2F); -160.11 (m, 2F); -117.53
(d, 2F); -158.12 (m, 1F); -150.46 (s, 4F-BF4); -147.11 (d, 2F).
IR (Nujol mull, cm-1): 1618 ν(CN); 1587 ν(CN).
instead of [Rh2(µ-Cl)2(COD)2] and [Pd(C6F5)(4,4′-Me-bipy)(PPy3)]-
(BF4) (150.0 mg, 0.185 mmol) instead of [Pd(C6F5)(4,4′-Me2-bipy)-
(PPhPy2)](BF4). Yield: 125.4 mg (55%). Anal. Calcd for C45H30N5B2-
F17PPdRh: C, 44.10; H, 2.47; N, 5.71. Found: C, 43.93; H, 2.64;
N, 5.60. 31P NMR (293 K, (CD3)2CO): δ 46.70. 1H NMR (293 K,
(CD3)2CO): δ 9.70 (t, 2H, H-3-Pycoord); 9.08 (d, 2H, H-6-Pycoord);
8.86 (d, 1H, H-6-Pynoncoord); 8.72 (s, 1H, 4,4′-Me2-bipy); 8.63 (s,
1H, 4,4′-Me2-bipy); 8.30 (t, 3H, H-4-Pycoord); 8.30 (t, 3H, H-3-
Pynoncoord); 8.06 (m, 1H, H-4-Pynoncoord); 7.92 (m, 1H, 4,4′-Me2-
bipy); 7.92 (m, 3H, H-5-Pycoord); 7.83 (m, 1H, H-5-Pynoncoord); 7.56
(d, 2H, 4,4′-Me2-bipy); 7.05 (d, 1H, 4,4′-Me2-bipy); 5.22 (m, broad,
TFB); 4.05 (m, broad, 4H-TFB); 2.60 (s, 3H, 4,4′-Me2-bipy); 2.50
(s, 3H, 4,4′-Me2-bipy); 1.30 (m, broad, 2H-TFB). 19F NMR (293
K, (CD3)2CO): δ -160.48 (m, 2F); -160.03 (m, 2F-TFB);
-157.83 (m, 1F); -150.43 (s, 4F-BF4); -146.95 (d, 2F-TFB);
-116.77 (d, 2F). 31P NMR (310K, (CD3)2CO): δ 50.89. IR (Nujol
mull, cm-1): 1622 ν(CN); 1590 ν(CN); 1574 ν(CN); 1564 ν(CN).
To register NMR spectra in CD2Cl2, the anion BF4 was exchanged
with BAF following the same procedure described above for 5.
[(C6F5)Au(µ-PPhPy2)Rh(COD)](BF4) (10). To a stirred solution
of [Rh2(µ-Cl)2(COD)2] (115.0 mg, 0.233 mmol) in 15 mL of acetone
was added solid TlBF4 (135.9 mg, 0.466 mmol). After 30 min,
[Au(C6F5)(PPhPy2)] (293.0 mg, 0.466 mmol) was added to the
solution. The mixture was stirred for 30 min more, the TlCl formed
was filtered through Celite, and the solvent was evaporated to 5
mL. The addition of ethanol (20 mL) and further evaporation of the
remaining acetone gave the product as a yellow crystalline solid that
was filtered and vacuum-dried. Yield 334.0 mg (77%). Anal. Calcd
for C30H25N2AuBF9PRh: C, 38.91; H, 2.72; N, 3.02. Found: C,
1
38.67; H, 2.75, N, 2.96. 31P NMR (293 K CDCl3) δ : 34.55. H
NMR (293 K CDCl3): δ 4.50 (m, 2H-olefin); 4.27 (m, 2H-olefin);
2.98 (m, 2H); 2.51 (m, 2H); 2.18 (m, 2H); 1.90 (m, 2H). 19F NMR
(293 K CDCl3): δ -164.5 (tdt, 2F); -160.42 (t, 1F); -156.92 (s,
4F); -119.52 (d, 2F). IR (Nujol mull, cm-1): 1587 ν(CN).
[(C6F5)Au(µ-PPhPy2)Rh(TFB)](BF4) (11). Prepared as 10 but
using [Rh2(µ-Cl)2(TFB)2] (173.0 mg, 0.234 mmol) instead of [Rh2-
(µ-Cl)2(COD)2]. Yield 370.0 mg (74%). Anal. Calcd for C34H19N2-
AuBF13PRh: C, 39.11; H, 1.82; N, 2.68. Found: C, 38.96; H, 1.88;
1
N, 2.77. 31P NMR (293 K (CD3)2CO): δ 36.39. H NMR (293 K
(CD3)2CO): δ 9.12 (d, 2H); 8.45 (m, 2H); 8.10 (m, 3H); 7.99 (m,
2H); 7.76 (m, 2H); 7.65 (m, 2H); 6.31 (broad, 1H); 5.63 (broad,
1H); 4.87 (broad, 2H); 4.57 (broad, 2H). IR (Nujol mull, cm-1):
1588 ν(CN).
Preparation of a Solution of [(4,4′-Me2-bipy)(C6F5)Pd(µ-
PPhPy2)Rh(TFB)] [B(3,5-C6H3(CF3)2)4]2 (5b). To a solution of
5 (15 mg, 0.012 mmol) in acetone was added NaBAF (24 mg, 0.027
mmol); the resulting solution was filtered to remove NaBF4, and
the solvent was evaporated. The residue was dissolved in ether,
filtered again, and evaporated to dryness, giving a residue that was
insoluble in CDCl3 but quite soluble in CD2Cl2.
[(4,4′-Me2-bipy)(C6F5)Pd(µ-PPy3)Rh(COD)](BF4)2 (6). Pre-
pared as described for 4 but using [Pd(C6F5)(4,4′-Me2-bipy)(PPy3)]-
(BF4) (150.0 mg, 0.185 mmol) instead of [Pd(C6F5)(4,4′-Me-
bipy)(PPhPy2)](BF4). Yield 147.1 mg (72%). Anal. Calcd for
C41H36N5B2F13PPdRh: C, 44.46; H, 3.28; N, 6.32. Found: C, 44.12;
H, 3.17; N, 6.10. 31P NMR (293 K, (CD3)2CO): δ 47.92. 1H NMR
(293 K, (CD3)2CO): δ 9.78 (broad, 2H); 9.34 (d, 2H); 8.74 (d,
1H); 8.66 (s, 4,4′-Me2-bipy, 1H); 8.57 (s, 4,4′-Me2-bipy, 2H); 8.26
(m, 2H); 8.07 (m, 2H); 7.95 (m, 2H); 7.82 (m, 4,4′-Me2-bipy, 1H);
7.69 (m, 1H); 7.51 (d, 4,4′-Me2-bipy, 1H); 6.92 (d, 4,4′-Me2-bipy,
1H); 6.78 (m, 4,4′-Me2-bipy, 1H); 2.59 (s, 4,4′-Me2-bipy, 3H); 2.41
(s, 4,4′-Me2-bipy, 3H). 19F NMR (293 K, (CD3)2CO): δ -160.56
(m, 2F); -158.14 (m, 1F); -150.26(s, 4F-TFB); -117.42 (broad,
1F); -115.83 (broad, 1F). IR (Nujol mull, cm-1): 1622 ν(CN);
1588 ν(CN); 1572 ν(CN).
[(C6F5)Au(µ-PPy3)Rh(COD)](BF4) (12). Prepared as 10 but
using [Rh2(µ-Cl)2(COD)2] (117.6 mg, 0.238 mmol), TlBF4 (139.0
mg, 0.477 mmol), and [Au(C6F5)(PPy3)] (300.0 mg, 0.477 mmol)
instead of [Au(C6F5)(PPhPy2)]. Yield 295.0 mg (67%). Anal. Calcd
for C29H24N3AuBF9PRh: C, 37.57; H, 2.60; N, 4.53. Found: C,
1
37.38; H, 2.83; N, 4.33. 31P NMR (293 K CDCl3): δ 29.94. H
NMR (293 K CDCl3): δ 9.09 (d, 2H, H-6-Pycoord); 9.00 (d, 1H,
H-6-Pynoncoord); 8.90 (t, 1H, H-3-Pynoncoord); 8.20 (m, 1H, H-4-
Pynoncoord); 7.84 (m, 2H, H-4-Pycoord); 7.80 (m, 1H, H-5-Pynoncoord);
7.64 (t, 2H, H-5-Pycoord); 7.24 (m, 2H, H-3-Pycoord); 4.58 (m, 2H-
olefin); 4.32 (m, 2H-olefin); 3.02 (m, 2H); 2.52 (m, 2H); 2.14 (m,
2H); 1.90 (m, 2H). 19F NMR (293 K CDCl3): δ -165.40 (t, 2F);
-159.95 (t, 1F); -156.36 (s, 4F, BF4); -119.48 ppm (d, 2F). 13
C
NMR (293 K CDCl3): δ 154.6 (C-6-Pycoord); 153.0 (C-6-Pynoncoord);
138.8 (C-4-Pycoord); 138.3 (C-4-Pynoncoord); 137.6 (C-3-Pynoncoord);
130.8 (C-3-Pycoord); 128.5 (C-5-Pynoncoord); 127.7 (C-5-Pycoord); 92.6
(C-olefin); 87.9 (C-olefin); 32.1 (COD); 29.8 (COD). IR (Nujol
mull, cm-1): 1589 ν(CN); 1575 ν(CN).
[(4,4′-Me2-bipy)(C6F5)Pd(µ-PPy3)Rh(TFB)](BF4)2 (7). Pre-
pared as 4 but using [Rh2(µ-Cl)2(TFB)2] (67.1 mg, 0.092 mmol)
[(C6F5)Au(µ-PPy3)Rh(TFB)](BF4) (13). Prepared as 12 but
using [Rh2(µ-Cl)2(TFB)2] (174.0 mg, 0.240 mmol) instead of [Rh2-
Inorganic Chemistry, Vol. 45, No. 17, 2006 6635